INKT
Mink Therapeutics Inc
12.40$
-2.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +0.2% | +0.5% | -16.2% | +38.9% | -14.0% | -5.8% | -3.9% | -10.5% | -11.7% | -6.5% | 0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.4% | -23.0% | -27.8% | -70.6% | +160.1% | -10.2% | +45.7% | -37.8% | +32.4% | -20.4% | +56.7% | – | |
| – | +21.9% | -41.5% | -17.1% | +9.5% | -30.4% | +157,009.2% | -99.9% | +99,757.5% | +264.2% | -75.1% | -99.9% | – | |
| – | +5.3% | -30.7% | -24.4% | -42.6% | +31.7% | +14.8% | +46.6% | -19.1% | +9.9% | -12.1% | +11.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.